Back
Bicycle Therapeutics PLC Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison
Sell
23
BCYC
Bicycle Therapeutics PLC
Last Price:
23.55
Seasonality Move:
6.64%
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
5.56
Seasonality Move:
-38.2%
Sell
23
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC a Buy, Sell or Hold?
- The current Bicycle Therapeutics PLC [BCYC] share price is $23.60. The Score for BCYC is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- BCYC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals PLC [BDRX] share price is $5.55. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BCYC Stock Price Chart
What is Bicycle Therapeutics PLC's stock price today?
-
The Bicycle Therapeutics PLC share price today is $23.60
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCYC is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals PLC's stock price today?
-
The Biodexa Pharmaceuticals PLC share price today is $5.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDRX is experiencing slight selling pressure.
BCYC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 50.63 | Buy |
| Chaikin Money Flow: | 228119 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.65 - 25.87) | Sell |
| Bollinger Bands (100): | (21.08 - 24.4) | Buy |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.71 | Buy |
| Relative Strength Index (14 RSI): | 23.86 | Sell |
| Chaikin Money Flow: | -18156 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-0.67 - 2.27) | Buy |
| Bollinger Bands (100): | (0.08 - 1.62) | Buy |
BCYC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.93 | Buy |
| 20-day SMA: | 24.51 | Sell |
| 50-day SMA: | 23.41 | Buy |
| 200-day SMA: | 22.17 | Buy |
| 8-day EMA: | 23.11 | Buy |
| 20-day EMA: | 23.48 | Buy |
| 50-day EMA: | 23.33 | Buy |
| 200-day EMA: | 22.43 | Buy |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.66 | Buy |
| 20-day SMA: | 0.89 | Buy |
| 50-day SMA: | 0.71 | Buy |
| 200-day SMA: | 1.17 | Buy |
| 8-day EMA: | 2.45 | Buy |
| 20-day EMA: | 1.34 | Buy |
| 50-day EMA: | 0.91 | Buy |
| 200-day EMA: | 14.86 | Sell |
Bicycle Therapeutics PLC Earnings Growth & BCYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.05 per share, and a decrease next year of $0.34 per share.
Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
Bicycle Therapeutics PLC Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals PLC Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||